Mark C . Gibson

Learn More
1Global Biological Standards Institute, Washington, DC, USA. 2Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA. 3Prostate Cancer Foundation, Milken Institute, Santa Monica, California, USA. 4Department of Discovery Oncology, Genentech Inc., South San Francisco, California, USA. 5ATCC, Manassas, Virginia, USA.(More)
The development of novel therapeutics depends and builds upon the validity and reproducibility of previously published data and findings. Yet irreproducibility is pervasive in preclinical life science research and can be traced to cumulative errors or flaws in several areas, including reference materials, study design, laboratory protocols, and data(More)
The development and promulgation of drinking water regulations to protect exposed human populations from contaminants that may occur in public drinking water supplies has been a major regulatory concern and effort of the United States Environmental Protection Agency for decades. Risk assessment, as applied in the development of drinking water regulations,(More)
A method alternative to the EPA’s determination of microorganisms of regulatory concern for drinking water quality is proposed. Drinking water in the U.S. is among the safest in the world but outbreaks of disease linked to drinking water still occur. For example, from 1991 to 2002 there were 183 reported waterborne disease outbreaks caused by chemical(More)
16 Vol. 61 | No. 1 | 2016 Antibodies are indispensable biological reagents in basic and translational research laboratories, as well as in clinical settings around the world. Research antibodies can be classified into the following major categories according to production method (ranging from oldest to most recent technologies): polyclonal, monoclonal, and(More)
  • 1